China · Delayed Price · Currency is CNY Verve Therapeutics Statistics
Total Valuation
SHE:301171 has a market cap or net worth of CNY 14.70 billion. The enterprise value is 12.16 billion.
| Market Cap | 14.70B |
| Enterprise Value | 12.16B |
Important Dates
The next estimated earnings date is Tuesday, August 19, 2025.
| Earnings Date | Aug 19, 2025 |
| Ex-Dividend Date | Nov 21, 2024 |
Share Statistics
SHE:301171 has 471.15 million shares outstanding. The number of shares has increased by 1.04% in one year.
| Current Share Class | 471.15M |
| Shares Outstanding | 471.15M |
| Shares Change (YoY) | +1.04% |
| Shares Change (QoQ) | +0.09% |
| Owned by Insiders (%) | 32.96% |
| Owned by Institutions (%) | 9.02% |
| Float | 276.44M |
Valuation Ratios
The trailing PE ratio is 62.46 and the forward PE ratio is 48.00.
| PE Ratio | 62.46 |
| Forward PE | 48.00 |
| PS Ratio | 4.91 |
| PB Ratio | 4.04 |
| P/TBV Ratio | 4.17 |
| P/FCF Ratio | 35.39 |
| P/OCF Ratio | 34.59 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 52.34, with an EV/FCF ratio of 29.27.
| EV / Earnings | 51.15 |
| EV / Sales | 4.06 |
| EV / EBITDA | 52.34 |
| EV / EBIT | 57.77 |
| EV / FCF | 29.27 |
Financial Position
The company has a current ratio of 2.67, with a Debt / Equity ratio of 0.11.
| Current Ratio | 2.67 |
| Quick Ratio | 2.62 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | 1.72 |
| Debt / FCF | 0.96 |
| Interest Coverage | 10.27 |
Financial Efficiency
Return on equity (ROE) is 6.63% and return on invested capital (ROIC) is 3.15%.
| Return on Equity (ROE) | 6.63% |
| Return on Assets (ROA) | 2.39% |
| Return on Invested Capital (ROIC) | 3.15% |
| Return on Capital Employed (ROCE) | 5.72% |
| Revenue Per Employee | 3.41M |
| Profits Per Employee | 270,389 |
| Employee Count | 879 |
| Asset Turnover | 0.54 |
| Inventory Turnover | 1,854.81 |
Taxes
| Income Tax | -9.94M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +140.93% in the last 52 weeks. The beta is 0.46, so SHE:301171's price volatility has been lower than the market average.
| Beta (5Y) | 0.46 |
| 52-Week Price Change | +140.93% |
| 50-Day Moving Average | 27.55 |
| 200-Day Moving Average | 28.06 |
| Relative Strength Index (RSI) | 56.10 |
| Average Volume (20 Days) | 46,680,008 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:301171 had revenue of CNY 2.99 billion and earned 237.67 million in profits. Earnings per share was 0.50.
| Revenue | 2.99B |
| Gross Profit | 498.60M |
| Operating Income | 210.43M |
| Pretax Income | 225.52M |
| Net Income | 237.67M |
| EBITDA | 218.70M |
| EBIT | 210.43M |
| Earnings Per Share (EPS) | 0.50 |
Balance Sheet
The company has 2.97 billion in cash and 400.15 million in debt, giving a net cash position of 2.57 billion or 5.45 per share.
| Cash & Cash Equivalents | 2.97B |
| Total Debt | 400.15M |
| Net Cash | 2.57B |
| Net Cash Per Share | 5.45 |
| Equity (Book Value) | 3.64B |
| Book Value Per Share | 7.76 |
| Working Capital | 3.26B |
Cash Flow
In the last 12 months, operating cash flow was 425.03 million and capital expenditures -9.67 million, giving a free cash flow of 415.36 million.
| Operating Cash Flow | 425.03M |
| Capital Expenditures | -9.67M |
| Free Cash Flow | 415.36M |
| FCF Per Share | 0.88 |
Margins
Gross margin is 16.65%, with operating and profit margins of 7.03% and 7.94%.
| Gross Margin | 16.65% |
| Operating Margin | 7.03% |
| Pretax Margin | 7.53% |
| Profit Margin | 7.94% |
| EBITDA Margin | 7.30% |
| EBIT Margin | 7.03% |
| FCF Margin | 13.87% |
Dividends & Yields
This stock pays an annual dividend of 0.14, which amounts to a dividend yield of 0.45%.
| Dividend Per Share | 0.14 |
| Dividend Yield | 0.45% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 2 |
| Payout Ratio | 33.89% |
| Buyback Yield | -1.04% |
| Shareholder Yield | -0.58% |
| Earnings Yield | 1.62% |
| FCF Yield | 2.83% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SHE:301171 has an Altman Z-Score of 4.77 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.77 |
| Piotroski F-Score | 5 |